Table 68Observed and expected prevalence of congenital malformations in babies of women with type 1 and type 2 diabetes (from CEMACH)266

Type of malformationBabies of women with type 1 diabetes, observed
(expected)a
Babies of women with type 2 diabetes, observed
(expected)a
Standardised prevalence ratio for babies of women with both type1 and type 2 diabetes (95% CI)
One or more malformations81 (37)28 (12.8)2.2 (1.8 to 2.6)
Neural tube defects6 (2.4)4 (0.9)4.2 (2.0 to 7.8)
Other central nervous system5 (1.7)0 (0.6)1.5 (0.3 to 3.6)
Eye1 (2.4)0 (0.9)1.0 (0.1 to 7.0)
Ear0 (0.7)0 (0.3)
Congenital heart disease33 (8.9)9(3.4)3.4 (2.5 to 4.6)
Cleft lip and palate0 (1.3)0 (0.5)
Cleft palate2 (0.9)0 (0.3)1.6 (0.2 to 5.9)
Digestive system1 (2.6)2 (1.0)0.8 (0.2 to 2.5)
Internal urogenital system9 (6.1)1 (2.3)1.2 (0.6 to 2.2)
External genital system3 (2.5)2 (0.9)1.5 (0.5 to 3.4)
Limb15 (10.2)4 (3.7)1.4 (0.8 to 2.1)
Other (non-chromosomal)64
Trisomy 2120
Other chromosomal22
a

Expected rates are based on European Surveillance of Congenital Anomalies (EUROCAT) 2002.267

From: 5, Antenatal care

Cover of Diabetes in Pregnancy
Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period.
NICE Guideline, No. 3.
National Collaborating Centre for Women's and Children's Health (UK).
Copyright © 2015 National Collaborating Centre for Women's and Children's Health.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.